Document is current
Any future updates will be listed below
-
Authors
,
Vodencarevic, Asmir
Tascilar, Koray
Hartmann, Fabian
Reiser, Michaela
Hueber, Axel J.
Haschka, Judith
Bayat, Sara
Meinderink, Timo
Knitza, Johannes
Mendez, Larissa
Hagen, Melanie
Krönke, Gerhard
Rech, Jürgen
Manger, Bernhard
Kleyer, Arnd
Zimmermann-Rittereiser, Marcus
Schett, Georg
Simon, David http://orcid.org/0000-0001-8310-7820
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR2886 PANDORA, CRC1181 Checkpoints for Resolution of Inflammation)
Bundesministerium für Bildung und Forschung (MASCARA)
ERC Synergy grant (4D Nanoscope)
Innovative Medicines Initiative (RTCure)
Friedrich-Alexander-Universität Erlangen-Nürnberg (Emerging Fields Initiative MIRACLE)
Else Kröner-Fresenius-Stiftung (Memorial Scholarship (No. 2019_EKMS.27))
- License Information
-
More Information
Article History
Received: 13 April 2020
Accepted: 10 February 2021
First Online: 27 February 2021
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the Friedrich-Alexander University of Erlangen-Nuremberg, Germany (approval number Az:01_2010) and all local ethics committees of the external centers as well as the Paul-Ehrlich Institute; the study was conducted according to the ethical principles of the Declaration of Helsinki. Patients’ written informed consent was obtained.
: Not applicable
: None to declare.
